Search research articles
Contact Us
Filters
Showing results (371-380 of 445) with videos related to
Page
of 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
Kent W Mouw, James M Cleary, Brendan Reardon, et al.
NPJ Precision Oncology
|
August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors
Aaron S Mansfield, David S Hong, Christine L Hann, et al.
Journal for Immunotherapy of Cancer
|
October 13, 2020
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
Albiruni Ra Razak, James M Cleary, Victor Moreno, et al.
The New England Journal of Medicine
|
May 14, 2015
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
Robert J Mayer, Eric Van Cutsem, Alfredo Falcone, et al.
Cell Reports. Medicine
|
April 8, 2023
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
Naiara Perurena, Rebecca Lock, Rachel A Davis, et al.
Breast (Edinburgh, Scotland)
|
February 28, 2026
A complex survivorship intervention utilizing electronic patient-reported outcomes in breast and gynecologic Cancer: the linking you to support and advice [LYSA] trial
Katie E Johnston, Kate O'Connell, Laia Raigal-Aran, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes
Vishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
The New England Journal of Medicine
|
March 31, 2021
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J Kelly, Jaffer A Ajani, Jaroslaw Kuzdzal, et al.
The Oncologist
|
February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial
Aminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial
Yelena Y Janjigian, Jaffer A Ajani, Markus Moehler, et al.
Page
of 45
Search research articles
Search
Showing results (371-380 of 445) with videos related to
Sort By:
Page
of 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
Kent W Mouw, James M Cleary, Brendan Reardon, et al.
NPJ Precision Oncology
|
August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors
Aaron S Mansfield, David S Hong, Christine L Hann, et al.
Journal for Immunotherapy of Cancer
|
October 13, 2020
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
Albiruni Ra Razak, James M Cleary, Victor Moreno, et al.
The New England Journal of Medicine
|
May 14, 2015
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
Robert J Mayer, Eric Van Cutsem, Alfredo Falcone, et al.
Cell Reports. Medicine
|
April 8, 2023
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
Naiara Perurena, Rebecca Lock, Rachel A Davis, et al.
Breast (Edinburgh, Scotland)
|
February 28, 2026
A complex survivorship intervention utilizing electronic patient-reported outcomes in breast and gynecologic Cancer: the linking you to support and advice [LYSA] trial
Katie E Johnston, Kate O'Connell, Laia Raigal-Aran, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes
Vishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
The New England Journal of Medicine
|
March 31, 2021
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J Kelly, Jaffer A Ajani, Jaroslaw Kuzdzal, et al.
The Oncologist
|
February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial
Aminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial
Yelena Y Janjigian, Jaffer A Ajani, Markus Moehler, et al.
Page
of 45